Jul 12, 2024 08:19AM
Apr 18, 2024 01:20AM
Apr 18, 2024 01:20AM
Apr 18, 2024 01:20AM
Apr 18, 2024 01:20AM
Apr 18, 2024 01:20AM
Apr 18, 2024 01:20AM Biophytis Announces New Scientific Advisory Board for its Phase 2 OBA Clinical Study in Obesity
Apr 18, 2024 01:20AM
Sep 27, 2023 05:45PM
Oct 31, 2022 07:10PM
Jun 28, 2022 05:45AM
Jun 27, 2022 05:45PM
Apr 19, 2022 05:53AM
Apr 19, 2022 02:20AM Biophytis: Biophytis Presents Sarconeos (BIO101) Development Program in Sarcopenia at the 12th Annual International Conference on Frailty and Sarcopenia Research (ICFSR) in Boston April 20-22, 2022
Apr 7, 2022 05:52AM
Apr 7, 2022 02:25AM
Apr 7, 2022 02:25AM
Nov 22, 2021 05:20PM
Oct 4, 2021 02:00AM
Sep 17, 2021 02:00AM
Sep 15, 2021 02:00AM Biophytis Announces DMC Second Interim Analysis Efficacy Results in the Promising Zone Allowing Continuation of Phase 2/3 COVA Study With Sarconeos (BIO101) in COVID-19
Sep 9, 2021 02:00AM
Jun 30, 2021 05:00PM
May 12, 2021 02:00AM
Apr 26, 2021 02:00AM
Feb 26, 2021 02:00AM
Feb 10, 2021 05:58AM
Feb 10, 2021 02:00AM Biophytis Announces Pricing of $20.1 Million U.S. Initial Public Offering of American Depositary Shares and Approval to List on Nasdaq Capital Market
Feb 3, 2021 05:49AM
Feb 3, 2021 02:00AM

322,093 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All